Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
Public ClinicalTrials.gov record NCT00241514. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo or Esomeprazole 20 mg Once Daily Versus Placebo in Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs
Study identification
- NCT ID
- NCT00241514
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 334 participants
Conditions and interventions
Conditions
Interventions
- Esomeprazole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2001
- Primary completion
- Jan 31, 2003
- Completion
- Jan 31, 2003
- Last update posted
- Jan 20, 2011
2001 – 2003
United States locations
- U.S. sites
- 19
- U.S. states
- 10
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tucson | Arizona | — | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Orange | California | — | — |
| Research Site | San Francisco | California | — | — |
| Research Site | Bradenton | Florida | — | — |
| Research Site | Clearwater | Florida | — | — |
| Research Site | Fort Lauderdale | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | South Miami | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Zephyrhills | Florida | — | — |
| Research Site | Conyers | Georgia | — | — |
| Research Site | Newburgh | Indiana | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Tulsa | Oklahoma | — | — |
| Research Site | Tipton | Pennsylvania | — | — |
| Research Site | Norfolk | Virginia | — | — |
| Research Site | Virginia Beach | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00241514, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 20, 2011 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00241514 live on ClinicalTrials.gov.